SP
SGX Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BVF PARTNERS L P/IL, was filed 11 Jul 2008.
SGX Pharmaceuticals, Inc.: what insiders have been doing
This page follows insider dealings at SGX Pharmaceuticals, Inc. as filed with SEC (Form 4). SGX Pharmaceuticals, Inc. has had no insider filing for more than a year; the last one goes back to 27 August 2008.
Looking back to 2006, when coverage begins, insiders filed 18 purchases and 62 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
147
Thresholds
n/a
Buy Volume
€9M
18 ops. · all time
Sell Volume
€140,164
62 ops. · all time
Last declaration on 27 August 2008
Declarations147 total
- 1,342,774 shares@ US$3.00Common StockSEC:0001233840-08-000021:0
- 914,700 shares@ US$3.00Common StockSEC:0001233840-08-000021:1
- 3,250,200 shares@ US$3.00Common StockSEC:0001233840-08-000021:2
- 2,546,747 shares@ US$3.00Common StockSEC:0001209191-08-048825:0
- 12,500 shares@ US$3.00Common StockSEC:0001240122-08-000014:0
- 25,005 shares@ US$3.00Common StockSEC:0001240122-08-000009:0
- 97,165 shares@ US$3.00Common StockSEC:0001240122-08-000013:0
- 100,000 shares@ US$3.00Common StockSEC:0001240122-08-000007:0
- 24,223 shares@ US$3.00Common StockSEC:0001240122-08-000011:0
- 55,731 shares@ US$3.00Common StockSEC:0001240122-08-000008:0
- 1,562 shares0Common StockSEC:0001351888-08-000015:0
- 781 shares@ US$2.98Common StockSEC:0001351888-08-000015:1
- 1,563 shares0Common StockSEC:0001350091-08-000016:0
- 781 shares@ US$2.96Common StockSEC:0001350091-08-000016:1
- 1,563 shares0Common StockSEC:0001351888-08-000013:0
- 681 shares@ US$3.05Common StockSEC:0001351888-08-000013:1
- 100 shares@ US$3.06Common StockSEC:0001351888-08-000013:2
- 20,100 shares@ US$2.9939Common StockSEC:0001233840-08-000019:0Canonical exit: 6 Oct 2008 (T+90)
- 14,000 shares@ US$2.9939Common StockSEC:0001233840-08-000019:1Canonical exit: 6 Oct 2008 (T+90)
- 48,000 shares@ US$2.9939Common StockSEC:0001233840-08-000019:2Canonical exit: 6 Oct 2008 (T+90)
- 197,300 shares@ US$3.0415Common StockSEC:0001233840-08-000019:3Canonical exit: 7 Oct 2008 (T+90)
- 135,000 shares@ US$3.0415Common StockSEC:0001233840-08-000019:4Canonical exit: 7 Oct 2008 (T+90)
- 468,000 shares@ US$3.0415Common StockSEC:0001233840-08-000019:5Canonical exit: 7 Oct 2008 (T+90)
- 99,200 shares@ US$3.0298Common StockSEC:0001233840-08-000019:6Canonical exit: 8 Oct 2008 (T+90)
- 68,000 shares@ US$3.0298Common StockSEC:0001233840-08-000019:7Canonical exit: 8 Oct 2008 (T+90)
25 of 147 declarations
About SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for cancer and other serious diseases. It specializes in the discovery and commercialization of innovative drugs.
